IMAGO PHARMACEUTICALS INC has a total of 21 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CONFLUENCE LIFE SCIENCES INC, UNIVABLOT and CALITOR SCIENCES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Bowers Simeon | 13 |
#2 | Sham Hing L | 11 |
#3 | Hom Roy K | 11 |
#4 | Probst Gary D | 9 |
#5 | Neitz R Jeffrey | 9 |
#6 | Toth Gergely | 9 |
#7 | Truong Anh | 9 |
#8 | Sealy Jennifer | 9 |
#9 | Konradi Andrei W | 8 |
#10 | Chen Karen | 7 |
Publication | Filing date | Title |
---|---|---|
EP3509586A1 | Treatment of fibrotic disorders with jun n-terminal kinase inhibitors | |
US2019330315A1 | Therapeutic antibodies for treatment of neurodegeneration | |
AU2015215863A1 | Inhibitors of jun n-terminal kinase | |
AU2010210426A1 | Inhibitors of Jun N-terminal kinase |